Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

CompletedOBSERVATIONAL
Enrollment

207

Participants

Timeline

Start Date

April 1, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Glabellar Lines
Interventions
BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over at least 5 years.

Trial Locations (5)

Unknown

Coral Gables

South Yarra

São Paulo

Niagara Falls

Cannes

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY